歡迎您來(lái)到深圳欣博盛生物科技有限公司網(wǎng)站!
JPT Peptide Technologies GmbH公司簡(jiǎn)介:
JPT Peptide Technologies GmbH是專注于肽基藥物研發(fā)與蛋白質(zhì)組學(xué)服務(wù)的德國(guó)企業(yè),總部位于柏林,致力于多肽合成、肽庫(kù)開發(fā)及免疫監(jiān)測(cè)技術(shù)。 ?

(JPT Peptide Technologies GmbH公司一角)
提供微縮肽合成(10-50 nmol至公斤級(jí)生產(chǎn))、肽庫(kù)及微陣列服務(wù),涵蓋抗原發(fā)現(xiàn)、免疫療法開發(fā)等應(yīng)用場(chǎng)景。其專-利技術(shù)包括微陣列制備工藝和高通量篩選方法,可實(shí)現(xiàn)蛋白質(zhì)功能研究和藥物篩選。
JPT Peptide Technologies GmbH公司擁有超過150名員工,其中30人擁有大學(xué)學(xué)位,20人具備博士學(xué)位。管理層包括生物技術(shù)碩士奧里恩·克萊森(2024年出任CEO),以及擁有光學(xué)科學(xué)碩士學(xué)位的西爾克·波廷格(COO)。公司自2004年起通過ISO 9001認(rèn)證,采用國(guó)際標(biāo)準(zhǔn)化生產(chǎn)流程。

(JPT Peptide Technologies GmbH產(chǎn)品圖)
JPT Peptide Technologies GmbH公司在國(guó)內(nèi)的授權(quán)代理商不多,一共五家。從JPT Peptide Technologies GmbH網(wǎng)站上能查詢到的信息,欣博盛生物【公司英文名簡(jiǎn)寫:Neobioscience】是其合規(guī)的代理商,正牌授權(quán)代理商,負(fù)責(zé)JPT Peptide Technologies GmbH公司的產(chǎn)品在中國(guó)地區(qū)的銷售及售前技術(shù)支持。欣博盛生物公司成立于2007年,在生物試劑行業(yè)一直保持著良好的口碑,20余年一直盡心盡力在服務(wù)好每一位科研工作者。

(JPT Peptide Technologies GmbH代理商頁(yè)面信息)
JPT Peptide Technologies GmbH產(chǎn)品較多,將近四千來(lái)款,且每年都會(huì)開發(fā)很多新產(chǎn)品。下面列舉的是JPT Peptide Technologies GmbH部分產(chǎn)品,供大家參考。如需購(gòu)買這些產(chǎn)品,可聯(lián)系JPT Peptide Technologies GmbH授權(quán)代理商欣博盛生物。
JPT Peptide Technologies GmbH部分產(chǎn)品列表:
| 產(chǎn)品貨號(hào) | 產(chǎn)品名稱 |
| AT-MA_01 | Acetylome - Deacetylase Microarray |
| AT-MA_02 | Acetylome - Acetyltransferase Microarray |
| CAMCheck-1000pm | CAMCheck Kit |
| CAMCheck-10pm | CAMCheck Kit |
| EMPS-229E-S-1 | Epitope Mapping Peptide Set (EMPS) HCoV-229E (Spike Glycoprotein) |
| EMPS-CVHSA-S-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV (Spike Glycoprotein) |
| EMPS-HKU1-S-1 | Epitope Mapping Peptide Set (EMPS) HCoV-HKU1 (Spike Glycoprotein) |
| EMPS-MERS-CoV-S-1 | Epitope Mapping Peptide Set (EMPS) MERS-CoV (Spike Glycoprotein) |
| EMPS-NL63-S-1 | Epitope Mapping Peptide Set (EMPS) HCoV-NL63 (Spike Glycoprotein) |
| EMPS-OC43-S-1 | Epitope Mapping Peptide Set (EMPS) HCoV-OC43 (Spike Glycoprotein) |
| EMPS-WCPV-NCAP-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV-2 (NCAP) |
| EMPS-WCPV-S-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV-2 (Spike Glycoprotein) |
| EMPS-WCPV-VEMP-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV-2 (VEMP) |
| EMPS-WCPV-VME-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV-2 (VME1) |
| His_MA_01 | Histone Code Peptide Microarrays |
| PM-229E-NCAP-1 | PepMix HCoV-229E (NCAP) |
| PM-229E-S-1 | PepMix HCoV-229E (Spike Glycoprotein) |
| PM-229E-S-2 | PepMix HCoV-229E (Spike Glycoprotein) |
| PM-AAV2-VP1 | PepMix AAV2 (Capsid Protein VP1) |
| PM-AAV5-CP | PepMix AAV5 (Capsid Protein) |
| PM-AAV6-VP1 | PepMix AAV6 (Capsid protein VP1) |
| PM-AAV8-CP | PepMix AAV8 (Capsid protein) |
| PM-AAV9-VP1 | PepMix AAV9 (Capsid Protein VP1) |
| PM-ACTL8 | PepMix Human (ACTL8) |
| PM-ACTS | PepMix Human (Actin) |
| PM-AFP | PepMix Human (AFP) |
| PM-AQP4 | PepMix Human (Aquaporin-4) |
| PM-ASPFU-CRF1 | PepMix Aspergillus fumigatus (Probable glycosidase crf1) |
| PM-ASPFU-GEL1 | PepMix Aspergillus fumigatus (Glucanosyltransferase gel1) |
| PM-BKV-AGP | PepMix BKV (Agnoprotein) |
| PM-BKV-LTA | PepMix BKV (large T antigen) |
| PM-BKV-STA | PepMix BKV (small T antigen) |
| PM-BKV-VP1 | PepMix BKV (capsid protein VP1) |
| PM-BKV-VP2 | PepMix BKV (capsid protein VP2) |
| PM-BKV-VP3 | PepMix BKV (capsid protein VP2, isoform VP3) |
| PM-BKV-VP4 | PepMix BKV (Viroporin) |
| PM-BORR-OSPA-1 | PepMix Borrelia (OspA protein) Ultra |
| PM-BRAC | PepMix Human (Brachyury) |
| PM-BRAF | PepMix Human (BRAF) |
| PM-C-BKV-1 | PepMix Collection BKV (2x1ug/peptide) |
| PM-C-BKV-2 | PepMix Collection BKV (25ug/peptide) |
| PM-C-cyCMV-2 | PepMix Collection Cynomolgus CMV (25 ug/peptide/vial) |
| PM-C-EBV-1 | PepMix Collection EBV (2x1ug/peptide) |
| PM-C-HCMV-1 | PepMix Collection Human CMV (2x1ug/peptide) |
| PM-C-HCMV-2 | PepMix Collection Human CMV (25ug/peptide) |
| PM-C-HPV-01 | PepMix Collection Papillomavirus |
| PM-C-HPV-E6 | PepMix Collection HPV (E6) |
| PM-C-HPV-E7 | PepMix Collection HPV (E7) |
| PM-C-Mel | PepMix Collection Melanoma |
| PM-C-SARS2-NSP-1 | PepMix Collection SARS-CoV-2 Wuhan Non-Structural Proteins |
| PM-C-SARS2-NSP-2 | PepMix Collection SARS-CoV-2 Wuhan Non-Structural Proteins |
| PM-C-SARS2-RBDMUT-1 | PepMix Collection SARS-CoV-2 S-RBD Mutations |
| PM-C-SARS2-SMUT-1 | PepMix Collection SARS-CoV-2 Spike Mutations |
| PM-C-SARS2-WSP-1 | PepMix Collection SARS-CoV-2 Wuhan Structural Proteins |
| PM-C-SARS2-WSP-2 | PepMix Collection SARS-CoV-2 Wuhan Structural Proteins |
| PM-C1 | PepMix Human (HLA classI Ig-like C1 type domain) |
| PM-CAND-MP65 | PepMix Candida (MP65) |
| PM-CCHFV-MP | PepMix Crimean-Congo hem. fever virus (M Polyprotein / IbAr10200) |
| PM-CCHFV-NP | PepMix Crimean-Congo hem. fever virus (Nucleoprotein / IbAr10200) |
| PM-CEA | PepMix Human (CEA) |
| PM-CEF-E-1 | CEF Pool (extended) |
| PM-CEF-E-2 | CEF Pool (extended) |